Cargando…
Prediction of Lung Shunt Fraction for Yttrium-90 Treatment of Hepatic Tumors Using Dynamic Contrast Enhanced MRI with Quantitative Perfusion Processing
There is no noninvasive method to estimate lung shunting fraction (LSF) in patients with liver tumors undergoing Yttrium-90 (Y90) therapy. We propose to predict LSF from noninvasive dynamic contrast enhanced (DCE) MRI using perfusion quantification. Two perfusion quantification methods were used to...
Autores principales: | Zhang, Qihao, Lee, Kyungmouk Steve, Talenfeld, Adam D., Spincemaille, Pascal, Prince, Martin R., Wang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680251/ https://www.ncbi.nlm.nih.gov/pubmed/36412683 http://dx.doi.org/10.3390/tomography8060224 |
Ejemplares similares
-
Trans-arterial hepatic radioembolisation of yttrium-90 microspheres
por: Murthy, R, et al.
Publicado: (2006) -
Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis
por: Kim, Hyo-Cheol
Publicado: (2022) -
Quantitative and Qualitative Assessment of Yttrium-90 PET/CT Imaging
por: Attarwala, Ali Asgar, et al.
Publicado: (2014) -
Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study
por: Maughan, Nichole M., et al.
Publicado: (2018) -
Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
por: Raval, Mihir, et al.
Publicado: (2014)